FDA approves durvalumab for adults with limited-stage small cell #LungCancer (LS-SCLC) who have not progressed after concurrent platinum-based chemotherapy and radiation. Efficacy was demonstrated in the ADRIATIC trial https://buff.ly/3OCSXfz @stephenvliu.bsky.social @biagioricciutimd.bsky.social

Dear Colleagues A Pleasure to introduce some our #OncoAlertAF Associate Faculty 🚨 @elisaagostinetto.bsky.social 🇧🇪 @elisabettabonzano.bsky.social 🇮🇹 @realbowtiedoc.bsky.social 🇺🇸 @biagioricciutimd.bsky.social 🇺🇸 @weoncologists.bsky.social 🇺🇸 @drnataliagandur.bsky.social 🇦🇷